P/E ratio for Diagnosticos da America (DASA) (DASA3.SA)
P/E ratio as of May 2024 (TTM): -2.76
According to Diagnosticos da America (DASA)'s latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -2.76079. At the end of 2022 the company had a P/E ratio of -19.8.
P/E ratio history for Diagnosticos da America (DASA) from 2009 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -19.8 | -76.26% |
| 2021 | -83.4 | -64.11% |
| 2020 | -232 | -265.25% |
| 2019 | 141 | 209.84% |
| 2018 | 45.4 | -28.6% |
| 2017 | 63.6 | 9.82% |
| 2016 | 57.9 | -55.36% |
| 2015 | 130 | 209.33% |
| 2014 | 41.9 | 21.97% |
| 2013 | 34.4 | -32.77% |
| 2012 | 51.1 | 53.95% |
| 2011 | 33.2 | -43.15% |
| 2010 | 58.4 | 113.71% |
| 2009 | 27.3 |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.